100% accuracy
of data
of data
24/7 scientific
support
support
0% tolerance in
quality of product
quality of product
Stock Locations
- New Jersey, USA
- Czech Republic, EU
- Mumbai, India
* Stock subject to availability.
1346603-25-5Moxifloxacin Related Compound G
● In Stock
| Catalogue No.: | VL106010 |
|---|---|
| CAS No.: | 1346603-25-5 |
| Mol. Formula: | C21H25ClFN3O4 |
| Mol. Weight: | 437.89 |
Additional information on CAS 1346603-25-5
Parent drug
MoxifloxacinIUPAC Name
1-Cyclopropyl-6-fluoro-8-methoxy-7-[(4aR, 7aR)-octahydro-6H-pyrrolo[3, 4-b]pyridin-6-yl]-4-oxo-1, 4-dihydroquinoline-3-carboxylic acid hydrochlorideSynonyms
Moxifloxacin HCl (R, R)-Isomer ; (4aR, 7aR)-Moxifloxacin Hydrochloride ;ent-Moxifloxacin Hydrochloride;d-Moxifloxacin Hydrochloride; 1-Cyclopropyl-6-fluoro-1, 4-dihydro-8-methoxy-7-[(4aR, 7aR)-octahydro-6H-pyrrolo[3, 4-b]pyridin-6-yl]-4-oxo-3-quinolinecarboxylic Acid Hydrochloride; d-Moxifloxacin Hydrochloride; (4R, 7R)-Moxifloxacin Hydrochloride;Description
Moxifloxacin Related Compound G (CAS No: 1346603-25-5) or Moxifloxacin HCl (R, R)-Isomer is an impurity present in moxifloxacin that shows antibacterial activity including all major upper and lower respiratory tract pathogens, is one of the most active fluoroquinolones against pneumococci.References
Kumar, Y. Ravindra., et al. “Structural Identification and Characterization of Impurities in Moxifloxacin.†Journal of Pharmaceutical and Biomedical Analysis, vol. 34, no. 5, Mar. 2004, pp. 1125–29, https://doi.org/10.1016/j.jpba.2003.11.012. Barman Balfour, Julia A., and Harriet M. Lamb. “Moxifloxacin.†Drugs, vol. 59, no. 1, Jan. 2000, pp. 115–39, https://doi.org/10.2165/00003495-200059010-00010.Request a Quote
« * » indique les champs nécessaires
Other products related to Moxifloxacin impurities
Impurity structure
Parent Drug Name
CAS No.
Name of Impurity
Catalog No.
